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A B S T R A C T
Objective: Few studies have explored the association between inflammation and eating disorders and none used a
longitudinal design. We investigated the association between serum-levels of interleukin 6 (IL-6) and C-reactive
protein (CRP) measured in childhood and eating disorders and related behaviours and cognitions in adolescence
in a large general population sample.
Methods: We used data from the Avon Longitudinal Study of Parents and Children (ALSPAC). Our exposures
were thirds of IL6 and CRP derived from serum measurements taken at age nine years, and outcomes were eating
disorder diagnoses and self-reported disordered eating behaviours at ages 14, 16, and 18 years. We used uni-
variable and multivariable multilevel logistic regression models adjusting for a number of potential confounders,
including sex, fat mass, and pre-existing mental health difficulties.
Results: Our sample included 3480 children. Those in the top third of CRP had lower odds of binge eating (odds
ratio(OR):0.62, 95% confidence interval (CI):0.39,1.00,p “equals” 0.05) and fasting (OR:0.63, 95%
CI:0.38,1.07,p “equals” 0.09) after adjustment for confounders. We also observed weak associations of com-
parable magnitude for purging, anorexia nervosa, and bulimia nervosa. We did not find any associations be-
tween levels of IL6 and any of the outcomes under study.
Conclusions: There was little evidence of an association between CRP and IL-6 and adolescent eating disorder
outcomes. The inverse association observed between CRP and binge eating was unexpected, so caution is needed
when interpreting it. One possible explanation is that higher CRP levels could have a protective role for dis-
ordered eating by affecting appetitive traits.
1. Introduction
It is proposed that low-grade systemic inflammation may play a role
in the pathogenesis of a number of psychiatric disorders. Cross-sectional
studies have shown that individuals with depression and anxiety com-
monly display altered immunological profiles (Costello et al., 2019;
Osimo et al., 2019). Elevated serum concentrations of pro-inflammatory
cytokines, such as Interleukin-6 (IL-6) and C-Reactive Protein (CRP),
are also prospectively associated with depression (Khandaker et al.,
2014; Valkanova et al., 2013), lending plausibility to a putative causal
association. In addition, Mendelian randomization studies support po-
tential causal associations between IL-6, CRP and depression
(Khandaker et al., 2019, 2018). Eating disorders, related disordered
eating behaviours and cognitions are commonly comorbid with anxiety
and depression (Konttinen et al., 2019; Micali et al., 2015b; Solmi et al.,
2014). However, despite the burgeoning inflammation literature, only a
limited number of studies have investigated their association with pro-
inflammatory cytokines (Brambilla, 2001; Brambilla et al., 2001;
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Caroleo et al., 2019; Dalton et al., 2018a, 2018b; Germain et al., 2016;
Holden and Pakula, 1996; Kahl et al., 2004; Nakai et al., 2001; Pomeroy
et al., 1994; Raymond et al., 2000; Shank et al., 2016; Solmi et al.,
2015).
To the best of our knowledge, none of these studies used long-
itudinal designs measuring cytokines prior to the onset of eating dis-
orders, which are necessary to investigate whether inflammation is a
potential risk factor for these disorders. The majority of existing studies
used case-control designs in clinical populations. These designs are
susceptible to selection bias and reverse causation. Existing evidence
suggests that women with anorexia nervosa have higher levels of pro-
inflammatory cytokines IL-6, and lower levels of CRP during acute ill-
ness (Dalton et al., 2018a; Solmi et al., 2015). However, these bio-
markers return within normal ranges with weight restoration (Dalton
et al., 2018a; Solmi et al., 2015) indicating that reverse causation is
indeed plausible. Research on other eating disorders (e.g., bulimia
nervosa and binge-eating disorder) and disordered eating is scant, and
results from these studies are mixed, with limited evidence of cross-
sectional associations between binge eating and higher levels of CRP
(Shank et al., 2016; Succurro et al., 2015).
The aim of this study is to investigate whether serum levels of IL-6
and CRP at age nine years are associated with eating disorder diag-
noses, disordered eating behaviours and cognitions during adolescence
using a large UK general population prospective birth cohort.
2. Material and methods
2.1. Sample
We used data from the Avon Longitudinal Study of Parents and
Children (ALSPAC), a birth cohort that recruited 14,541 pregnancies
with an expected delivery date falling between 1st April 1991 and 31st
December 1992 in the region of Avon. These pregnancies resulted in
14,062 live births, with 13,988 children alive at one year of age (Boyd
et al., 2013; Fraser et al., 2013). The ALSPAC Law and Ethics committee
and the Local Research Ethics committees gave ethical approval for the
study. The study website (www.bristol.ac.uk/alspac) provides more
information on the sample and contains details of all the data that is
available through a fully searchable data dictionary: http://www.bris.
ac.uk/alspac/researchers/data-access/data-dictionary/.
In this study, we included children who were in the core ALSPAC
sample and alive at one year, and who had data available on both ex-
posures, and outcomes (described below in sections 2.2 and 2.3). In
case of twins, given their shared genetic and environmental exposures,
we retained one child at random to avoid biased inferences.
2.2. Outcomes
Adolescents reported on disordered eating behaviours occurring in
the previous 12 months at approximately age 14, 16, and 18 years via
postal questionnaires using a number of questions from the Youth Risk
Behavior Surveillance System (Brener et al., 1995), which have been
previously used in this sample (Bould et al., 2018; Micali et al., 2015a;
Solmi et al., 2018). These were: fasting for weight loss for at least
24 hours; purging (self-induced vomiting or laxative use) for weight
loss; and binge-eating (eating large amount of food in a short period of
time with a sense of loss of control). We considered these behaviours
present if they had occurred at least once a month and used them in-
dividually as outcomes. Adolescents also reported whether they had
dieted for at least one month and up to a year continuously. We ad-
ditionally created a variable indicating whether any of these behaviours
were present, in order to increase statistical power of the analyses. Body
Mass Index (BMI) was measured at clinics assessment that took place
when adolescents were 13.5, 15.5, and 17.5 years old and supple-
mented with self-reported measurements when objective measures
were not available as these are highly correlated in this sample
(r = 0.89). As recommended in case of adolescents, we used age- and
sex-standardised BMI measurements (Cole et al., 2007, 2000). From
these measures, we further derived eating disorder diagnoses of anor-
exia nervosa, bulimia nervosa, and binge-eating disorder using DSM-5
criteria. Although eating disorder diagnoses are uncommon and
therefore likely to result in underpowered statistical analyses, we in-
cluded them as outcomes to explore whether the associations appeared
to be consistent with those observed for the more broadly defined be-
haviours. At the age 14 years follow up, adolescents also reported on
two cognitive dimensions of eating disorders (body dissatisfaction and
weight and shape concerns). Body dissatisfaction was measured using
the Body Dissatisfaction Scale (Stice, 2001), weight and shape concerns
with three questions from the McKnight Risk Factor Survey (Shisslak
et al., 1999). In eMethods 1, we describe how we derived these out-
comes in detail.
2.3. Exposure
Serum-levels of IL-6 and CRP were obtained from non-fasting blood
samples when the children were on average 9.9 (standard deviation:
0.32) years of age during clinical assessments. More details on these
measurements are available in previous publications (Khandaker et al.,
2014). We restricted analyses to participants who had a CRP count <
10 mg/L, as values above this threshold might indicate active infection
(Pepys and Hirschfield, 2003), and used standardised values for ease of
interpretation. We used thirds of IL-6 and CRP to define equal size
groups as main exposures to allow for non-linear associations and, as
supplemental analyses also used continuous indicators further adding a
quadratic term to explore non-linear associations.
2.4. Confounders
In order to estimate the total effect of IL6 and CRP on our outcomes,
we adjusted our analyses for a pre-specified set of confounders (i.e.,
factors which we hypothesised could cause both the exposure and the
outcome, and thus represent alternative explanations for any observed
associations) after defining our causal assumptions using Direct Acyclic
Graphs (Fig. 1). These hypothesised associations were informed by
previous literature. These included child’s: sex (male/female), total fat
mass at the time of exposure measurement (age nine years), mental
health problems at age seven years (parentally-reported using the
Strength and Difficulties Questionnaire (SDQ) (Goodman, 1997)), and
child-reported peer victimization at age eight years. Childhood BMI is
longitudinally associated with greater disordered eating (Reed et al.,
2017). To account for this, we adjusted our analyses for fat mass as a
proxy for BMI, given the strong correlation between pro-inflammatory
cytokines and fat tissue and the known limitations of BMI as a mea-
surement of body composition (Dencker et al., 2007; Freedman et al.,
2005). Mental health difficulties (Flouri et al., 2020b) and peer victi-
misation (Takizawa et al., 2015) in childhood are associated with raised
inflammatory profiles and have been associated with disordered eating
(Lee and Vaillancourt, 2018; Sonneville et al., 2015).
Our causal assumptions also required adjustment for maternal age
and highest education at birth of study child (compulsory/non-com-
pulsory) as proxies for socio-economic position, depressive symptoms
(self-reported at 32 weeks of gestation using the Edinburgh Postnatal
Depression Scale (Murray and Carothers, 1990)), pre-pregnancy BMI,
and maternal reported stressful life events (self-reported at 32 weeks of
gestation), as proxy for stressful home environment. All of these factors
have been associated with increased levels of inflammation in the off-
spring (Flouri et al., 2020a; Godfrey et al., 2017; Milaniak and Jaffee,
2019; Plant et al., 2016) as well as greater odds of disordered eating
and eating disorders (Bould et al., 2015; Larsen et al., 2018; Micali
et al., 2018).
As shown in the DAG, we also hypothesized that genetic risk for the
outcomes, and existing autoimmune diseases (Raevuori et al., 2014;
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Zerwas et al., 2017) in the child could be confounders of the association
between the exposures and the outcomes. However, we were unable to
measure these as, with the exception of anorexia nervosa (Watson et al.,
2019), no adequately powered GWAS of disordered eating behaviours
currently exists (Boraska et al., 2012; Wade et al., 2013) and auto-
immune diseases are rare in children (Cooper and Stroehla, 2003).
More details on how these factors were measured in ALSPAC is pro-
vided in eMethods 2.
2.5. Data analysis
We described the sample characteristics using proportions with
percentages and median with interquartile ranges, given the skewed
nature of the exposures (eFigs. 2–3). We tabulated the prevalence of
disordered eating behaviours in our sample (as previously defined) and
among all participants who responded at 14, 16, and 18 years, to ex-
plore whether the two were comparable.
We investigated the association between our exposures (measured
both as categorical and as continuous exposures) and outcomes at 14,
16, and 18 years using multi-level univariable and multivariable lo-
gistic regression models accounting for repeated measurements within
participants. We ran three models: a univariable regression including
only exposure, outcome, and an indicator of age at outcome measure-
ment (14, 16, and 18 years) and two multivariable ones. In multi-
variable model one, we progressively adjusted for child’s sex and fat
mass. In multivariable model two, we included all other child- and
maternal-level confounders. We additionally fitted this model with an
interaction term between exposure and age to investigate the presence
of age-specific associations.
We tested the association between exposures and eating behaviours
and cognitions at age 14 using three linear regression models.
Univariable model, only included the exposure, multivariable model
one progressively adjusted for sex and fat mass, and multivariable
model two additionally including all other confounders.
We imputed missing confounder and outcome data in children with
complete exposure and disordered eating behaviours reported at, at
least, one follow-up point using multiple imputation with chained
equations and 50 imputations (eMethods 3). We also ran all models
Fig. 1. Direct Acyclic Graph (DAG) outlining our causal assumptions. The green square with triangle shape represents our exposures, whereas the blue square with
the rectangle represents our outcomes. Empty green squares represent ancestors of the exposure (i.e. factors we assumed to cause the exposure, but not the outcome).
Based on our causal assumptions, in order to calculate the total effect of inflammatory biomarkers IL-6 and CRP on the outcome, it was necessary to adjust our models
for: child’s sex, genetic risk for eating disorders, autoimmune disorders, fat mass at age nine years, mental health difficulties at age seven years, exposure to bullying
at age eight as well as maternal age, highest education (as a proxy for socio-economic position), depression, and stressful life events. Grey squares represent
confounders which we could adjust for, as this information is available in the ALSPAC dataset, while white circles represent variables which we were not able to
observe in the data. We discuss implication of not adjusting for these variables in the limitations section. Adjustment for child’s ethnicity, in red square, was not
required based on our assumptions. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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using complete cases. We used Stata 15 to conduct all analyses
(StataCorp, 2017). The protocol for this study was pre-registered and is
available at: https://osf.io/2pz59/.
3. Results
3.1. Sample and missing data
Fig. 2 shows a flowchart of study participation. At one year, 13,787
children in the core ALSPAC sample were alive. Of these, 7205 (52.2%)
attended clinic assessments at age 9 years, and 4652 (33.7%) had
complete data on both exposures, from blood samples.
Children missing exposure data were more likely to be males, to
have had greater mental health difficulties at seven years of age, or
having been bullied at age eight years. They were also more likely to
have younger and less educated mothers, who had greater depressive
symptoms. Children who attended the clinic assessment at age nine
years, but did not have data on blood sample had similar characteristics
with the exception that they were more likely to be girls (see eTable1).
Among those with complete exposure data, 2910 (62.6%) also had
data on weight and shape concerns, and body dissatisfaction scales at
age 14 years, and 3480 (74.8%) had data on disordered eating beha-
viours at, at least, one time point in adolescence. IL-6 and CRP were not
associated with missing outcome data. However, males, children with
mental health difficulties (indexed by above-threshold scores on the
SDQ), and those who had been bullied were more likely to have missing
outcome data. Greater maternal depressive symptoms, maternal BMI,
and younger age at child birth were also associated with greater attri-
tion (eTable 2).
Table 1 presents the characteristics of children with complete ex-
posure data. Median levels of both exposures were higher in girls, and
in children with greater fat mass, who had been bullied, and whose
mother had higher BMI. Median levels of IL-6 were also higher in
children whose families experienced more stressful life events, who had
younger mothers, and who had internalising or externalising symptoms.
3.2. Prevalence of eating disorder diagnoses and disordered eating
behaviors
At all ages, disordered eating behaviours and eating disorder diag-
noses were uncommon, though their prevalence increased across ado-
lescence. The prevalence of the outcomes in our analytical sample was
comparable to that in the overall sample (Table 2).
3.3. Associations between IL-6 and CRP at age nine and disordered eating
during adolescence
As shown in Table 3, in univariable models, children in the middle
and top third of IL-6 and CRP had greater odds of any disordered eating,
and in particular fasting and dieting in adolescence. We observed si-
milar associations for purging and binge eating, although these asso-
ciations were weak. Adjustment for child’s sex and fat mass in model
one, reduced the odds ratios across all outcomes. In this model, there
was no evidence of an association between IL-6 and any of the out-
comes across adolescence. However, there was some evidence that
children in the top third of CRP had lower odds of any disordered eating
(OR [odds ratio]: 0.71, 95% CI [confidence interval]: 0.51 to 0.98,
p = 0.03) binge eating (OR: 0.61, 95% CI: 0.38 to 1.00, p = 0.05) at
ages 14 to 18 years. We also observed associations of similar magnitude
for fasting (OR: 0.65, 95%CI: 0.38 to 1.10, p = 0.10) and purging (OR:
0.63, 95%CI: 0.32 to 1.26, p = 0.19) in adolescence, although for these
outcomes evidence of an association was weaker, particularly for pur-
ging. Further inclusion of all other confounders in model 2 resulted in
minimal changes to these associations (any disordered eating OR: 0.70,
95%CI: 0.51 to 0.97, p = 0.03, binge eating OR: 0.62, 95%CI: 0.39 to
1.00, p = 0.05; purging OR: 0.63, 95%CI: 0.32 to 1.27, p = 0.20;
fasting OR: 0.63, 95%CI: 0.38 to 1.07, p = 0.09). There was no evi-
dence of interactions between either exposures and time.
3.4. Associations between IL-6 and CRP at age nine and eating disorders
during adolescence
We observed a similar pattern of results using eating disorder di-
agnoses as outcomes (Table 3). In univariable models, children in the
middle and top third of IL-6 and CRP had greater odds of all diagnoses
in adolescence, with the exception of anorexia nervosa in relation to
CRP. Nevertheless, for all these associations, 95% confidence intervals
were wide and included the null. After adjustment for sex and fat mass
in model one, most of these associations were reduced (particularly
those pertaining to the top third of IL-6 and CRP) and remained un-
altered in model two. Here, we found that children in the top third of
CRP had lower odds of all diagnoses (anorexia nervosa OR: 0.65,
95%CI: 0.18 to 2.41, p = 0.52; bulimia nervosa OR: 0.55, 95%CI: 0.20,
1.55, p = 0.25, binge-eating disorder OR: 0.60, 95%CI: 0.22 to 1.61,
Fig. 2. Flow chart of study participation.
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p = 0.31) even though 95% CIs were wide and p-values large. Children
in the top third of IL-6 also had lower odds of both bulimia nervosa (OR:
0.76, 95%CI: 0.34 to 1.67, p = 0.49) and binge eating disorder (OR:
0.76, 95%CI: 0.31 to 1.85, p = 0.54). On the contrary, the odds of
anorexia nervosa for those in the middle and top third of IL-6 were not
reduced as much after adjustment for confounders (middle third, model
two OR: 1.30, 95%CI: 0.49 to 3.45, p = 0.59; top third model two OR:
1.20, 95%CI: 0.39 to 3.71, p = 0.75), although there was no evidence
of an association. There was also no evidence of interactions between
any of the exposures and time.
3.5. Associations between IL-6 and CRP at age nine and eating disorder
cognitions at age 14
In univariable models (Table 4) children in the middle and top third
of IL-6 and CRP had greater levels of weight and shape concerns and
body dissatisfaction. These associations disappeared after adjustment
for sex and fat mass in model one and remained unaltered in the fully
adjusted model two.
Table 1





4,652 0.80 (0.49,1.38) 0.21 (0.11, 0.52)
Sex
Male 2,352 (50.6%) 0.70 (0.45, 1.19) 0.16 (0.10, 0.39)
Female 2,300 (49.4%) 0.90 (0.56, 1.53) 0.28 (0.14, 0.67)
Tertiles of total fat mass
1st tertile (lowest) 1,540 (34.7%) 0.67 (0.42, 1.13) 0.13 (0.09, 0.25)
2nd tertile 1,488 (33.5%) 0.73 (0.46, 1.23) 0.20 (0.12, 0.40)
3rd tertile (highest) 1.411 (31.8%) 1.07 (0.68, 1.69) 0.48 (0.24, 1.03)
Child internalising/externalising problems age 7 years (SDQ)
Absent 2,328 (96.9%) 0.78 (0.49, 1.36) 0.21 (0.11, 0.51)
Present 140 (4.1%) 0.83 (0.54, 1.43) 0.17 (0.11, 0.42)
Maternal education
Compulsory 2,512 (55.9%) 0.82 (0.51, 1.40) 0.22 (0.12, 0.54)
Non-compulsory 1,984 (44.1%) 0.78 (0.47, 1.35) 0.20 (0.11, 0.49)
Maternal age
15–19 83 (1.8%) 0.98 (0.59, 1.43) 0.21 (0.12, 0.43)
20–25 902 (19.4%) 0.86 (0.54, 1.43) 0.24 (0.12, 0.60)
26–35 3,281 (70.5%) 0.78 (0.49, 1.39) 0.21 (0.11, 0.51)
36–44 386 (8.3%) 0.78 (0.49, 1.19) 0.19 (0.11, 0.46)
Maternal pre-pregnancy BMI
Underweight 185 (4.4%) 0.77 (0.46, 1.32) 0.19 (0.11, 0.40)
Normal weight 3,214 (76.0%) 0.77 (0.48, 1.32) 0.20 (0.11, 0.48)
Overweight 618 (14.6%) 0.87 (0.57, 1.54) 0.26 (0.13, 0.70)
Obese 211 (5.0%) 1.00 (0.57, 1.69) 0.33 (0.13, 0.84)
Maternal depression
No 3,807 (89.4%) 0.79 (0.50, 1.37) 0.21 (0.12, 0.52)
Yes 452 (10.6%) 0.81 (0.50, 1.37) 0.19 (0.12, 0.52)
Peer victimization at 8 years
No 2,645 (67.1%) 0.76 (0.48, 1.34) 0.21 (0.12, 0.54)
Yes 1,296 (32.9%) 0.84 (0.52, 1.47) 0.22 (0.11, 0.59)
Tertiles of Stressful Life Events score
1st tertile (lowest) 1,614 (37.9%) 0.77 (0.49, 1.34) 0.23 (0.12, 0.54)
2nd tertile 1,501 (35.3%) 0.79 (0.49, 1.34) 0.20 (0.11, 0.51)
3rd tertile (highest) 1,137 (26.7%) 0.82 (0.55, 1.42) 0.21 (0.12, 0.51)
List of abbreviations: CRP = C-Reactive Protein, IL-6 = Interleukin-6, IQR = interquartile range, SDQ = strengths and difficulties questionnaire.
Table 2
Frequency of disordered eating behaviors and diagnoses among those with complete exposure and at least two outcome measurements available and in each wave of
data collection overall.
Disordered eating behaviors (occurring at least monthly) Eating Disorder diagnoses
Any n(%) Dieting n(%) Fasting n(%) Binge eating n(%) Purging n(%) AN n(%) BN n(%) BED n(%)
Prevalence among children included in our sample (n = 3,480)
Age 14 224 (7.47%) 118 (3.94%) 69 (2.30%) 62 (2.07%) 18 (0.60%) 5 (0.18%) 11 (0.37%) 14 (0.47%)
N = 2,998
Age 16 374 (14.7%) 156 (6.13%) 145 (5.74%) 146 (5.74%) 87 (3.42%) 20 (0.86%) 23 (0.90%) 22 (0.86%)
N = 2,545
Age 18 313 (18.21%) 130 (7.56%) 92 (5.35%) 143 (8.32%) 76 (4.42%) 13 (0.82%) 29 (1.69%) 23 (1.34%)
N = 1,719
Prevalence among children with data available at each follow-up point
Age 14 448 (7.98%) 226 (4.03%) 154 (2.74%) 123 (2.19%) 37 (0.66%) 10 (0.21%) 25 (0.45%) 25 (0.45%)
N = 5,611
Age 16 740 (15.82%) 310 (6.63%) 280 (5.99%) 281 (6.01%) 179 (3.83%) 34 (0.85%) 48 (1.03%) 44 (0.94%)
N = 4,678
Age 18 585 (18.65%) 261 (8.31%) 172 (5.48%) 256 (8.15%) 147 (4.68%) 20 (0.73%) 49 (1.56%) 46 (1.46%)
N = 3,140
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3.6. Sensitivity analyses using IL-6 and CRP as continuous measures
Broadly, these results were similar to those of the main analyses
(eTables 3,4). We did not observe any associations between IL6 and any
of the outcomes. However, in multivariable model two, a standard
deviation increase in CRP was associated with lower odds of any dis-
ordered eating (OR: 0.87, 95%CI: 0.77 to 0.99, p = 0.03), fasting (OR:
0.79, 95%CI: 0.64 to 0.96, p = 0.02), and purging (OR: 0.73, 95%CI:
0.55 to 0.99, p = 0.04), albeit weakly so. There was also some evidence
of a non-linear association between CRP (CRP quadratic term p-
Table 3
Multilevel logistic models of the association between tertiles of IL6 and CRP and disordered eating behaviors and diagnoses at age 14, 16, and 18. Samples of
participants with complete exposure and at least one outcome measurements (n = 3,480, imputed confounders and outcomes in those with at least one available).
Outcomes Exposure: thirds of IL-6 Exposure: thirds of CRP
2nd third (vs 1st)
OR (95%CI) of outcomes
3rd third (vs 1st)
OR (95%CI) of outcomes
2nd third (vs 1st)
OR (95%CI) of outcomes
3rd third (vs 1st)
OR (95%CI) of outcomes
Fasting
Univariable 1.68 (1.16, 2.45) p = 0.006 1.97 (1.24, 3.14) p = 0.004 2.22 (1.49, 3.29) p = 0.001 1.95 (1.22, 3.13) p = 0.006
Multivariable model1 1.13 (0.77, 1.65) p = 0.53 1.06 (0.66, 1.71) p = 0.79 1.14 (0.77, 1.70) p = 0.52 0.65 (0.38, 1.10) p = 0.10
Multivariable model2 1.05 (0.72, 1.53) p = 0.81 0.98 (0.62, 1.57) p = 0.94 1.14 (0.77, 1.69) p = 0.51 0.63 (0.38, 1.07) p = 0.09
Dieting
Univariable 1.66 (1.19, 2.31) p = 0.003 2.36 (1.60, 3.47) p < 0.0001 2.67 (1.89, 3.76) p < 0.0001 4.05 (1.89, 3.76) p < 0.0001
Multivariable model1 0.94 (0.68, 1.31) p = 0.73 0.91 (0.61, 1.35) p = 0.64 1.23 (0.87, 1.73) p = 0.23 0.96 (0.61, 1.50) p = 0.86
Multivariable model2 0.92 (0.66, 1.28) p = 0.63 0.89 (0.60, 1.32) p = 0.56 1.23 (0.88, 1.73), p = 0.23 0.95 (0.61, 1.48), p = 0.81
Binge eating
Univariable 1.21 (0.87, 1.68) p = 0.25 1.30 (0.87, 1.92) p = 0.20 1.43 (1.01, 2.01), p = 0.04 1.39 (0.90, 2.26) p = 0.14
Multivariable model1 0.90 (0.65, 1.26) p = 0.56 0.83 (0.55, 1.25) p = 0.37 0.90 (0.64, 1.26) p = 0.54 0.61 (0.38, 1.00) p = 0.05
Multivariable model2 0.87 (0.63, 1.21) p = 0.42 0.80 (0.53, 1.20) p = 0.27 0.91 (0.65, 1.28) p = 0.59 0.62 (0.39, 1.00) p = 0.05
Purging
Univariable 1.53 (0.90, 2.56) p = 0.11 1.77 (0.90, 3.47) p = 0.09 1.95 (1.16, 3.32) p = 0.01 1.91 (1.00, 3.62) p = 0.05
Multivariable model1 0.98 (0.58, 1.66) p = 0.94 0.94 (0.47, 1.85) p = 0.84 1.01 (0.60, 1.68) p = 0.98 0.63 (0.32, 1.26), p = 0.19
Multivariable model2 0.95 (0.56, 1.60) p = 0.84 0.90 (0.46, 1.76) p = 0.76 1.03 (0.62, 1.70), p = 0.92 0.63 (0.32, 1.27), p = 0.20
Exposure: thirds of IL-6
2nd third (vs 1st)
OR (95%CI) of outcomes
3rd third (vs 1st)
OR (95%CI) of outcomes
2nd third (vs 1st)
OR (95%CI) of outcomes
3rd third (vs 1st)
OR (95%CI) of outcomes
Any disordered eating
Univariable 1.58 (1.23, 2.01), p< 0.0001 2.07 (1.55, 2.76),p< 0.0001 1.88 (1.46, 2.41), p<0.0001 3.31 (1.72, 3.13), p< 0.0001
Multivariable model1 1.02 (0.80, 1.31), p=0.84 1.05 (0.80, 1.40), p=0.72 0.98 (0.76, 1.25), p=0.84 0.71 (0.51, 0.98), p=0.03
Multivariable model2 0.99 (0.77, 1.25), p=0.91 1.00 (0.78, 1.25), p=0.97 0.98 (0.77, 1.25), p=0.87 0.70 (0.51, 0.97), p=0.03
Anorexia Nervosa
Univariable 1.59 (0.60, 4.17) p=0.34 1.56 (0.52, 4.63) p=0.43 2.05 (0.85, 4.92) p=0.11 0.88 (0.25, 3.10) p=0.85
Multivariable model1 1.35 (0.51, 3.64) p=0.54 1.28 (0.41, 3.96) p=0.67 1.47 (0.59, 3.59) p=0.41 0.65 (0.17, 2.44) p=0.52
Multivariable model2 1.30 (0.49, 3.45) p=0.59 1.20 (0.39, 3.71) p=0.75 1.51 (0.62, 3.70) p=0.36 0.65 (0.18, 2.41) p=0.52
Bulimia Nervosa
Univariable 1.21 (0.64, 2.28) p=0.55 1.32 (0.62, 2.81) p=0.47 2.50 (1.27, 4.96) p=0.009 1.36 (0.54, 3.47) p=0.52
Multivariable model1 0.88 (0.43, 1.65), p=0.68 0.80 (0.37, 1.77), p=0.59 1.56 (0.22, 1.59) p=0.28 0.57 (0.21, 1.59) p=0.28
Multivariable model2 0.84 (0.45, 1.59) p=0.59 0.76 (0.34, 1.67) p=0.49 1.54 (0.76, 3.09) p=0.23 0.55 (0.20, 1.55) p=0.25
Binge eating disorder
Univariable 1.39 (0.68, 2.87) p=0.37 1.55 (0.66, 3.61) p=0.31 1.41 (0.70, 2.87) p=0.33 1.61 (0.66, 3.96) p=0.30
Multivariable model1 0.97 (0.47, 2.00) p=0.93 0.83 (0.34, 2.02) p=0.68 0.80 (0.39, 1.64), p=0.55 0.60 (0.22, 1.61) p=0.31
Multivariable model2 0.92 (0.44, 1.90) p=0.81 0.76 (0.31, 1.85) p=0.54 0.82 (0.40, 1.67) p=0.58 0.60 (0.22, 1.61) p=0.31
Multivariable model 1: adjusted for sex, time, and total fat mass in grams at age 9 years. Multivariable model 2: adjusted for sex, time, total fat mass in grams at
age 9 years, maternal education, maternal age at child’s birth, maternal pre-pregnancy total fat mass in grams, maternal depression in pregnancy, mental health
difficulties (i.e., total strength and difficulties questionnaire score) at age 7 years, peer victimization at age 8 years, maternal experience of stressful life events in
pregnancy.
Table 4
Linear regression models for the association between tertiles of IL-6 and CRP and body dissatisfaction and weight and shape concerns at age 14 years (n = 2,901).
Outcomes Exposure: third of IL-6 Exposure: third of CRP
2nd third (vs 1st)
Mean difference (95%CI) in outcome
3rd third (vs 1st)
Mean difference (95%CI) in outcome
2nd third (vs 1st)
Mean difference (95%CI) in outcome
3rd third (vs 1st)
Mean difference (95%CI) in outcome
Body dissatisfaction
Univariable 1.66 (1.00, 2.32) p < 0.0001 2.48 (1.68, 3.30) p < 0.0001 2.60 (1.96, 3.24) p < 0.0001 4.11 (3.28, 4.92) p < 0.0001
Multivariable model1 0.01 (-0.59, 0.62) p = 0.96 0.06 (-0.70, 0.82) p = 0.88 0.54 (-0.07, 1.16) p = 0.08 0.22 (-0.61, 1.05) p = 0.60
Multivariable model2 −0.06 (-0.66, 0.55) p = 0.61 0.01 (-0.75, 0.76) p = 0.98 0.55 (-0.07, 1.17) p = 0.08 0.22 (-0.61, 1.05) p = 0.60
Weight & shape concerns
Univariable 0.41 (0.25, 0.57) p < 0.0001 0.65 (0.46, 0.84), p < 0.0001 0.62 (0.47, 0.78) p < 0.0001 0.91 (0.72, 1.10) p < 0.0001
Multivariable model1 0.03 (-0.11, 0.17) p = 0.64 0.09 (-0.08, 0.27), p = 0.28 0.14 (-0.01, 0.29), p = 0.05 0.03 (-0.16, 0.22) p = 0.76
Multivariable model2 0.01 (-0.13, 0.15), p = 0.84 0.08 (-0.10, 0.25) p = 0.38 0.15 (0.01, 0.29) p = 0.05 0.03 (-0.16, 0.22) p = 0.75
Multivariable model 1: adjusted for sex and total fat mass at age 9 years. Multivariable model 2: adjusted for sex, total fat mass at age 9 years, maternal education,
maternal age at child’s birth, maternal pre-pregnancy BMI, maternal depression in pregnancy, mental health difficulties (i.e., total strength and difficulties ques-
tionnaire score) at age 7 years, peer victimization at age 8 years, maternal experience of stressful life events in pregnancy.
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value = 0.09) and lower odds of binge eating (OR: 0.74, 95%CI: 0.55 to
0.99, p = 0.04). There were comparable associations between higher
CRP and lower odds of anorexia nervosa (OR: 0.53, 95%CI: 0.24 to
1.22, p = 0.14) and bulimia nervosa (OR: 0.71, 95%CI: 0.43 to 1.17,
p = 0.18).
In analyses run on complete cases (eTables 5,6), the only association
we observed was for lower odds of binge eating for children in the top
third of CRP (OR: 0.57, 95%CI: 0.35, 0.95, p = 0.03; eTable 5). All
other estimates were nevertheless compatible with those observed in
imputed data.
4. Discussion
In this study, we found no evidence of an association between serum
levels of IL-6 at age nine years and all of the outcomes investigated
measured in adolescence. There was weak evidence of an association
between high levels of CRP at age nine years and lower odds of fasting,
binge eating, and purging at ages 14 to 18 years. Although we adjusted
our analyses for sex, fat mass, pre-existing psychopathology, bullying,
and socio-demographic indicators, we cannot exclude the potential of a
chance finding or residual confounding, particularly in light of: the
weak associations found; the number of tests conducted; the observa-
tion that adjusting for confounding led to a large reduction in the as-
sociations; and the fact that we could not control for a number of po-
tential confounders identified in our DAG. Low statistical power could
also explain the weak associations we observed since the prevalence of
our outcomes was low and the confidence intervals around our esti-
mates wide.
4.1. Comparison with previous literature
Previous studies reported that women with anorexia nervosa have
higher levels of IL-6, but that these returned within the normal range
after weight restoration and improvement of psychological symptoms
(Dalton et al., 2018a; Solmi et al., 2015). This suggests that immune
alterations could be a consequence of illness rather than be its cause.
Likewise, we did not observe any longitudinal associations between IL-
6, restrictive eating behaviours, weight and shape concerns, body dis-
satisfaction (common phenotypical presentations of anorexia nervosa),
or anorexia nervosa. Therefore, we propose that, taken together, ex-
isting evidence suggests that IL-6 alterations could be a state marker of
anorexia nervosa rather than a risk factor for its development.
Case-control studies suggest that women with anorexia nervosa may
have lower levels of CRP (Solmi et al., 2015), although no studies have
investigated whether this association remains after weight restoration.
Despite differences in design and populations, our findings broadly
align with those of previous studies. Specifically, we found that higher
levels of CRP were associated with lower odds of fasting with similar
patterns observed when using anorexia nervosa as outcome (although,
here, statistical evidence of an association was absent). We also found
similar associations between higher levels of CRP and lower odds of
binge eating, purging, and bulimia nervosa (although for the latter two
evidence of an association was weak and absent, respectively). This is in
contrast with previous evidence of higher levels of CRP in people with
loss of control eating (Shank et al., 2016; Succurro et al., 2015).
However, it is possible that metabolic sequalae of binge eating, e.g.
dyslipidaemia (Hudson et al., 2010; Tanofsky-Kraff et al., 2012; Yoon
et al., 2019), could lead to higher levels of CRP, whereas our findings
could reflect aetiological mechanisms.
4.2. Strengths and limitations of this study
Strengths of this study include a prospective design, the use of a
large sample, and adjustment for multiple relevant confounders.
Limitations include limited inflammatory marker data. We only had
data on IL-6 and CRP at one time point in childhood. Future studies
should incorporate a wider range of markers at several time points in
childhood, as inflammation is a dynamic process and understanding ‘at
risk’ developmental stages would aid aetiological inferences.
Disordered eating behaviours were self-reported, which could have
resulted in misclassification, as eating disorders can be highly ego-
syntonic. However, the questions we included have been previously
used in a number of studies in ALSPAC (Bornioli et al., 2019; Reed
et al., 2017; Solmi et al., 2019) and other samples (Chin et al., 2018;
Field et al., 2012; Haines et al., 2009) and produced consistent results
suggesting that they likely capture core eating disorder presentations.
The prevalence of eating disorder diagnoses, as expected, was low,
though in line with their known epidemiology (Smink et al., 2013). This
likely resulted in low statistical power and type II errors. We never-
theless included these outcomes to explore the general pattern of as-
sociation between the exposures and more severe outcome presenta-
tions. We cannot exclude the potential for residual confounding,
including genetic confounding. Although there is a large GWAS of an-
orexia nervosa (Watson et al., 2019), currently there are no adequately
powered GWAS of disordered eating behaviors and related cognitions
(Boraska et al., 2012; Wade et al., 2013), bulimia nervosa, or binge-
eating disorder. Finally, a large proportion of the participants were lost
to follow up. To address this limitation, we imputed missing confounder
data under a missing at random assumption and compared estimates
with complete cases. We were reassured by the fact that results were
largely comparable, especially for the final models that included the
main drivers of missingness.
4.3. Interpretation of findings
The overall weak evidence we observe calls for caution when in-
terpreting our results. One biologically plausible explanation for our
findings is that – whilst cross-sectionally observed low levels of CRP in
anorexia nervosa could reflect immunosuppression following severe
weight loss – premorbid high levels of CRP could have anorexigenic
effects, and appetitive traits have been shown to be associated with
eating disorders (Herle et al., 2019). In both humans and mice, natu-
rally-occurring or experimentally-induced inflammation results in
‘sickness’ behaviour, characterised by low mood, reduced appetite and
weight loss (Dantzer, 2009). High levels of CRP (and IL-6) are believed
to be the main cause of cachexia—a syndrome whose symptoms include
anorexia and early satiety (Mahmoud and Rivera, 2002; Morley et al.,
2006)—and anorexia in elderly populations (Morley, 2001). It is pos-
sible that greater inflammation in childhood could act as an appetite-
suppressing factor. This could confer some degree of protection against
binge eating, by reducing overeating, a precursor of binge eating be-
haviours in adolescence (Herle et al., 2019). The association with lower
odds of restricting behaviours (i.e., fasting and purging) might be re-
flect fewer compensating behaviours in the absence of binge eating.
Appetitive traits (and, specifically, the effect that CRP exerts on them)
could represent one of many risk factors with an overall small effect
that our sample is unable to detect with sufficient precision. However,
as this is the first study that has investigated these associations, and we
only observed weak associations, replication of these findings in even
larger samples is warranted before hypotheses around potential me-
chanisms are formalised. Meanwhile, the overall lack of strong evidence
for an association between inflammatory markers and eating disorders
appears to be in contrast with what has been previously observed for
other conditions including as depression (Khandaker et al., 2019, 2018,
2014; Valkanova et al., 2013), often comorbid with eating disorders,
suggesting different aetiological pathways.
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